Schedule 13G ownership disclosure

Edgewise Therapeutics Inc

Security class unavailable · CUSIP: 28036F105

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-118917
Form type
SC 13G
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub